A61K 47/59
Obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
Official title: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
A61K47/59 (Obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds) appears on 4,995 US grants and 8,116 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,995
- Published applications
- 8,116
- Assignees
- 2,467
- Inventors
- 12,115
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 5 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 5 | 0 |
| 1988 | 7 | 0 |
| 1989 | 6 | 0 |
| 1990 | 12 | 0 |
| 1991 | 5 | 0 |
| 1992 | 18 | 0 |
| 1993 | 20 | 0 |
| 1994 | 23 | 0 |
| 1995 | 28 | 0 |
| 1996 | 37 | 0 |
| 1997 | 54 | 0 |
| 1998 | 52 | 0 |
| 1999 | 54 | 0 |
| 2000 | 38 | 0 |
| 2001 | 49 | 24 |
| 2002 | 59 | 89 |
| 2003 | 72 | 164 |
| 2004 | 47 | 163 |
| 2005 | 57 | 196 |
| 2006 | 83 | 193 |
| 2007 | 76 | 197 |
| 2008 | 83 | 239 |
| 2009 | 100 | 232 |
| 2010 | 142 | 332 |
| 2011 | 143 | 314 |
| 2012 | 172 | 315 |
| 2013 | 220 | 363 |
| 2014 | 254 | 403 |
| 2015 | 275 | 435 |
| 2016 | 280 | 480 |
| 2017 | 278 | 421 |
| 2018 | 313 | 405 |
| 2019 | 303 | 466 |
| 2020 | 271 | 392 |
| 2021 | 274 | 462 |
| 2022 | 237 | 426 |
| 2023 | 223 | 412 |
| 2024 | 226 | 418 |
| 2025 | 223 | 356 |
| 2026 | 147 | 219 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Therapeutic carbon nanomaterial H2S oxidants for biological polysulfide synthesis6 Oct 2026US 12,752,017 B2The Texas A&M University System
- Bio-functionalization of water-soluble poly(phenylene ehtylene)s6 Oct 2026US 12,753,271 B2Board of Regents, The University of Texas System
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Dynamic-covalent hydrogels with glucose-specific and glucose-responsive diboronate crosslinking29 Sep 2026US 12,746,277 B2University of Notre Dame du Lac
- Antitumor pharmaceutical composition and use thereof29 Sep 2026US 12,746,289 B2Jenkem Technology Co., Ltd. (Tianjin)
- Polymer-based therapeutics for inductive browning of fat8 Oct 2026US 2026/0306643 A1Purdue Research Foundation
- Human interleukin-2 variant or derivative thereof8 Oct 2026US 2026/0308220 A1Jiangsu Hengrui Medicine Co., Ltd.
- Targeted engineered interferon and uses thereof8 Oct 2026US 2026/0308221 A1Orionis Biosciences BV
- Glucagon-like peptide-1 receptor agonist variants and methods thereof1 Oct 2026US 2026/0295054 A1
- Glp-1r/gipr/gcgr triple agonist analogue and use thereof1 Oct 2026US 2026/0295055 A1Shenzhen Bay Laboratory
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Uncharged morpholino-based polymers having achiral intersubunit linkages1,700US 5,034,506 AAnti-Gene Development Group · 1991
- Polyhydroxyalkanoate compositions having controlled degradation rates1,516US 6,867,248 B1Metabolix, Inc. · 2005
- Alpha-morpholino ribonucleoside derivatives and polymers thereof900US 5,235,033 AAnti-Gene Development Group · 1993
- Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages851US 5,185,444 AAnti-Gene Deveopment Group · 1993